The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Burlev V.A.

Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova, Moskva

Il'iasova N.A.

Nauchnyĭ tsentr akusherstva, ginekologii i perinatologii im. akad. V.I. Kulakova, Moskva

Accents of molecular markers expression profiling in eutopic and ectopic endometrium in endometriosis

Authors:

Burlev V.A., Il'iasova N.A.

More about the authors

Journal: Russian Journal of Human Reproduction. 2018;24(5): 82‑94

Read: 2151 times


To cite this article:

Burlev VA, Il'iasova NA. Accents of molecular markers expression profiling in eutopic and ectopic endometrium in endometriosis. Russian Journal of Human Reproduction. 2018;24(5):82‑94. (In Russ.)
https://doi.org/10.17116/repro20182405182

Recommended articles:
Use of gona­dotropic releasing hormone agonists in hype­rplastic syndrome in gyne­cology. Russian Bulletin of Obstetrician-Gynecologist. 2025;(4):51-58
The possibilities of realizing reproductive function in women with endo­metrial hype­rplasia. Russian Bulletin of Obstetrician-Gynecologist. 2025;(5):98-105

References:

  1. Buis CC, van Leeuwen FE, Mooij TM, Burger CW; OMEGA Project Group. Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis. Human Reproduction. 2013;28(12):3358-3369. https://doi.org/10.1093/humrep/det340
  2. Heidemann LN, Hartwell D, Heidemann CH, Jochumsen KM. The relation between endometriosis and ovarian cancer — a review. Acta Obstetricia et Gynecologica Scandinavica. 2014;93(1):20-31. https://doi.org/10.1111/aogs.12255
  3. Brunson GL, Barclay DL, Sanders M, Araoz CA. Malignant extraovarian endometriosis: two case reports and review of the literature. Gynecologic Oncology. 1988;30(1):123-130. https://doi.org/10.1016/0090-8258(88)90055-8
  4. Mostoufizadeh M, Sculli R. Malignant tumors arising in endometriosis. Clinical Obstetrics and Gynecology. 1980;23:951-963. https://doi.org/10.1097/00003081-198023030-00024
  5. Stern RC, Dash R, Bentley RC, Snyder MJ, Haney AF, Robboy SJ. Malignancy in endometriosis: frequency and comparison of ovarian and extraovarian types. International Journal of Gynecological Pathology. 2001;20:133-139. https://doi.org/10.1097/00004347-200104000-00004
  6. Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D’Hooghe T, De Bie B, Heikinheimo O, Horne AW, Kiesel L, Nap A, Prentice A, Saridogan E, Soriano D, Nelen W; European Society of Human Reproduction and Embryology. ESHRE guideline: management of women with endometriosis. Human Reproduction. 2014;29(3):400-412. https://doi.org/10.1093/humrep/det457
  7. Chernukha GYe, Ilyina LM, Pavlovich SV. Endometriosis as a risk factor for cardiovascular disorders and certain malignancies. Doctor.ru. 2017;3(132):43-48. (In Russ.)
  8. Johnson NP, Hummelshoj L. World Endometriosis Society Montpellier Consortium. Consensus on current management of endometriosis. Human Reproduction. 2013;28(6):1552-1568. https://doi.org/10.1093/humrep/det050
  9. Fat BC, Terzibachian JJ, Govyadovskiy A, Grisey A. Postmenopausal malignant transformation of extragenital endometriosis. A case report. Gynecologie, Obstetrique and Fertilite. 2008;36(1):51-55. https://doi.org/10.1016/j.gyobfe.2007.06.019
  10. Benoit L, Arnould L, Margarot A, Franceschini C, Collin F, Fraisse J, Cuisenier J. Malignant tumours arising in extraovarian endometriosis: three cases reports and review of the literature. Annals of Surgery. 2004;129:376-380. https://doi.org/10.1016/j.anchir.2004.04.014
  11. Paillocher N, Pessaux P, Catala L, Maillard P, Croue A, Arnaud JP, Descamps P. Malignant tumors arising in extra-ovarian endometriosis: a case report. J Gynecol Obstet Biol Reprod. 2005;34:501-503.
  12. Modesitt SC, Tortolero-Luna G, Robinson JB, Gershenson DM, Wolf JK. Ovarian and extraovarian endometriosis-associated cancer. Obstetrics and Gynecology. 2002;100(4):788-795.
  13. Marchand E, Hequet D, Thoury A, Barranger E. Malignant transformation of superficial peritoneal endometriosis lesion. BMJ Case Reports. 2013;2013:bcr2012007730. https://doi.org/10.1136/bcr-2012-007730
  14. Beiko D, Bryson SCP., Bell CD, Pace KT. Laparoscopic excision of a cystic retroperitoneal adenocarcinoma arising in a focus of extra-ovarian endometriosis. Canadian Urological Association Journal. 2010;4(3):E71-E73.
  15. Burlev VA, Ilyasova NA. Sex hormone levels and the nucleons isoforms expression of estrogen and progesterone receptors in eutopic endometrium of patients with peritoneal form endometriosis and infertility. Problemy reproduktsii. 2016;22(4):66-75. (In Russ.) https://doi.org/10.17116/repro201622466-75
  16. Bourlev V, Volkov N, Pavlovitch S, Lets N, Larsson A, Olovsson M. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction. 2006;132:501-509. https://doi.org/10.1530/rep.1.01110
  17. Burlev VA, Ilyasova NA, Sarkisov SE. The measurement of angiogenic factors in blood of patients with endometrial hyperplasia. Problemy reproduktsii. 2011;6:16-25. (In Russ.)
  18. Burlev VA, Ilyasova NA, Sarkisov SE. Angiogenesis growth factors in structural components of endometrium: role VEGF-A165 at endometrial hyperplasia. Voprosy ginekologii, akusherstva i perinatologii. 2012;1:11-19. (In Russ.)
  19. Burlev VA, Sarkisov SE, Ilyasova NA, Burlev AV. Hyperplasia of eutopic endometrium: abnormal and angiogenesis. Problemy reproduktsii. 2007;5:21-27. (In Russ.)
  20. Burlev VA, Sarkisov SE, Ilyasova NA, Dubinskaya ED, Burlev AV. Endometrial microvessels in patients with hyperplasia and adenocarcinoma. Problemy reproduktsii. 2008;4:10-16. (In Russ.)
  21. Ilyasova NA, Burlev VA, Sarkisov SE. Endometrial hyperplasia: proliferative activity index and expression of estrogen and progesterone receptors and their subtypes. Voprosy ginekologii, akusherstva i perinatologii. 2009;5:15-22. (In Russ.)
  22. Burlev VA, Ilyasova NA. Neuroangiogenesis in endometrium of women with endometriosis and chronic pelvic pain: high expression of vasoactive intestinal peptide. Problemy reproduktsii. 2017;23(4):87-97. (In Russ.). https://doi.org/10.17116/repro201723487-97]
  23. Burlev VA, Burlev AV. Expression of Cox in the eutopic and ectopic endometrium in patients with peritoneal endometriosis form. Problemy reproduktsii. 2007;2:45-51. (In Russ.)
  24. Ogawa S, Kaku T, Amada S, Kobayashi H, Hirakawa T, Ariyoshi K, Kamura T, Nakano H. Ovarian endometriosis associated with ovarian carcinoma: a clinicopathologic and immunohistochemical study. Gynecologic Oncology. 2000;77:298-304. https://doi.org/10.1006/gyno.2000.5765
  25. Sayasneh A, Tsivos D, Crawford R. Endometriosis and ovarian cancer: a systematic review. ISRN Obstetrics and Gynecology. 2011;2011: 140310. https://doi.org/10.5402/2011/140310
  26. Burlev VA, Fedorova TA, Pshenichnikova TJa. Sposob diagnostiki jendometrioza. Avtorskoe svidetel’stvo SSSR; 1986: №1273799, Bjul.44. Accessed February 02, 2018. (In Russ.). Available at:] https://patents.su/3-1273799-sposob-diagnostiki-ehndometrioza.html
  27. Warburg O. On the origin of cancer cells. Science. 1956;123:309-314. https://doi.org/10.1126/science.123.3191.309
  28. Smith SK. Regulation of angiogenesis in the endometrium. Trends in Endocrinology and Metabolism. 2001;12(4):147-151. https://doi.org/10.1016/S1043-2760(01)00379-4
  29. Burlev VA. Autoparacrine disorders of angiogenesis regulation in proliferative forms of diseases of the female reproductive system. Akusherstvo i ginekologiya. 2006;3:34-40. (In Russ.)
  30. Burlev VA. Proliferative and angiogenic activity of endometriomas. Problemy reproduktsii. 2016;22(3):91-100. (In Russ.) https://doi.org/10.17116/repro201622391-100
  31. Denneberg AJ, Altorki NK, Boyle JO, Dang C, Howe LR, Weksler BB, Subbaramaiah K. Cyclo-oxyganase 2: a pharmacological target for the prevention of cancer. Lancet Oncology. 2001;2(9):544-551. https://doi.org/10.1016/S1470-2045(01)00488-0
  32. Volpert OV, Dameron KM, Bouck N. Sequential development of an angiogenic phenotype by human fibroblastprogressing to tumorigenicity. Oncogene. 1997;14:495-1502. https://doi.org/10.1038/sj.onc.1200977
  33. Moberg C, Bourlev V, Ilyasova N, Olovsson M. Endometrial expression of LIF and its receptor and peritoneal fluid levels of IL-1a and IL-6 in women with endometriosis are associated with the probability of pregnancy. Archives of Gynecology and Obstetrics. 2015;292(2):429-437. https://doi.org/10.1007/s00404-015-3626-0
  34. Krawczyk N, Banys-Paluchowski M, Schmidt D, Ulrich U, Fehm T. Endometriosis-associated malignancy. Geburtshilfe und Frauenheilkunde. 2016;76(2):176-181. https://doi.org/10.1055/s-0035-1558239
  35. Wilbur MA, Shih IM, Segars JH, Fader AN. Cancer implications for patients with endometriosis. Seminars in Reproductive Medicine. 2017;35(1):110-116. https://doi.org/10.1055/s-0036-1597120
  36. Burlev VA, Ilyasova NA, Shishkanova OA. Cyclic angiogenesis of the eutopic endometrial. Problemy reproduktsii. 2006;6:22-30. (In Russ.)
  37. Basu GD, Pathangecy LB, Tinder TL, LaGioia M, Gendler SJ, Mukherjee P. Cox-2 inhibitor induces apoptosis in breast cancer cells in a vivo model of spontaneous metastatic breast cancer. Molecular Cancer Research. 2004;2(11):632-642.
  38. Burlev VA. Ectopic endometrium: proliferative activity and apoptosis in patients with peritoneal form of genital endometriosis. Problemy reproduktsii. 2012;6:7-13. (In Russ.)
  39. Burlev VA, Ilyasova NA. Angiogenic properties of endometrial aquaporins in patients with peritoneal endometriosis. Problemy reproduktsii. 2017;23(3):19-31. (In Russ.) https://doi.org/10.17116/repro201723319-31
  40. Burlev VA, Ilyasova NA, Volkov NI, Gasparov AS, Dubinskaja ED. Microvascular density and angiogenic activity in eutopic endometrium in patients with peritoneal endometriosis. Problemy reproduktsii. 2004;6:51-56. (In Russ.)

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.